Description
| - The aim of the European First Episode Schizophrenia Trial (EUFEST) is to compare treatment with amisulpride, quetiapine, olanzapine and ziprasidone to a low dose of haloperidol in an unselected sample of first episode schizophrenia patients with minimal prior exposure to antipsychotics. At present, more than 400 patients have been recruited and randomized in the following countries: Austria, Belgium, Bulgaria, Czech Republic, Germany, France, Israel, Italy, the Netherlands, Poland, Rumania, Spain, Sweden and Switzerland: The study should be finished by the end of 2006 and it is expected that results will yield relevant clinical information with regard to the effectiveness of the second generation antipsychotics. This effort represents the first independently designed trans-European schizophrenia treatment trial.
- The aim of the European First Episode Schizophrenia Trial (EUFEST) is to compare treatment with amisulpride, quetiapine, olanzapine and ziprasidone to a low dose of haloperidol in an unselected sample of first episode schizophrenia patients with minimal prior exposure to antipsychotics. At present, more than 400 patients have been recruited and randomized in the following countries: Austria, Belgium, Bulgaria, Czech Republic, Germany, France, Israel, Italy, the Netherlands, Poland, Rumania, Spain, Sweden and Switzerland: The study should be finished by the end of 2006 and it is expected that results will yield relevant clinical information with regard to the effectiveness of the second generation antipsychotics. This effort represents the first independently designed trans-European schizophrenia treatment trial. (en)
- Cíle: cílem the European first episode schizopherenia trial (EUFEST) je porovnání léčby amisulpridem, quetiapinem, olanzapinem a ziprasidonem s nízkými dávkami haloperidolu na vzorku pacientů po prvním ataku schizofrenie, kteří mají minimální předchozí zkušenosti s antipsychotiky. Do dnešní doby do studie vstoupilo více než 400 pacientů ze těchto zemí: Rakousko, Belgie, Bulharsko, Česká republika, Německo, Francie, Izrael, Itálie, Holandsko, Polsko, Rumunsko, atd. Studie by měla skončit na konci roku 2006. (cs)
|